Application progress of transcriptome sequencing in hematological malignancies / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 705-708, 2019.
Article
em Zh
| WPRIM
| ID: wpr-800703
Biblioteca responsável:
WPRO
ABSTRACT
Transcriptome sequencing (RNA-seq) has unique advantages in analyzing gene fusion, splicing mutations, and gene expression profiles. Single-cell RNA-seq provides powerful tools to reveal cellular heterogeneity in normal and tumor tissues. With the widespread application of high-throughput gene sequencing technology and the rapid reduction in cost, RNA-seq is increasingly used in hematological malignancies research. This article introduces the related research progress in conjunction with reports at the 61st American Society of Hematology Annual Meeting.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Journal of Leukemia & Lymphoma
Ano de publicação:
2019
Tipo de documento:
Article